TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/28/24 18:16 | 3/27/24 | GOSS | Gossamer Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Christian Waage | CA | O | EVP,Tech | S | -7 | 1.16 | 0 | -6 | -1 | 654 | D | ||||||||||||||
3/22/23 17:19 | 3/20/23 | GOSS | Gossamer Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Christian Waage | CA | O | EVP,Tech | P.d | 22 | 1.20 | 0 | 19 | 3 | 637 | I | ||||||||||||||
7/15/22 16:25 | 7/15/22 | GOSS | Gossamer Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Christian Waage | CA | O | EVP,Tech | P | 50 | 7.21 | 0 | 7 | 1 | 615 | I | ||||||||||||||
3/24/22 16:57 | 3/23/22 | GOSS | Gossamer Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Christian Waage | CA | O | EVP,Tech | S | -96 | 8.92 | 0 | -11 | -2 | 608 | D | ||||||||||||||
12/23/21 18:58 | 12/21/21 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Christian Waage | CA | D | S.d | -3 | 9.73 | 0 | 0 | -2 | 14 | D | |||||||||||||||
9/23/21 16:30 | 9/21/21 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Christian Waage | CA | D | S | -4 | 12.31 | 0 | 0 | -8 | 4 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |